Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 283

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1A
Chunk 283
---

    others may have
    access to any future intellectual property rights licensed to us on a non-exclusive basis;

    ●
    our competitors
    might conduct research and development activities in countries where we have or intend to pursue patent rights, and then use
    the information learned from such activities to develop competitive products for sale in our major commercial markets where
    we do not have patent rights;

    ●
    we may not develop
    additional proprietary technologies that are patentable;

    ●
    the patents or other
    intellectual property rights of others may have an adverse effect on our business; and

    ●
    we may choose not
    to file a patent application covering certain of our trade secrets or know-how, and a third party may subsequently file a
    patent covering such intellectual property.

Should
any of these events occur, they could significantly harm our business, financial condition, results of operations and prospects.

If
we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed. Our
reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor will discover
them or that our trade secrets will be misappropriated or disclosed.

In
addition to patent protection, we also rely on the protection of trade secrets, know-how and confidential and proprietary information.
The disclosure of our trade secrets would impair our competitive position and could harm our business. However, trade secrets
are difficult to protect. To maintain the confidentiality of trade secrets and proprietary information, we rely in part on confidentiality
agreements with our employees, consultants, outside scientific collaborators, sponsored researchers, and/or other advisors, and
inventions agreements with employees, consultants, and advisors, to protect our trade secrets and other proprietary information.
These agreements require that all confidential information developed by the individual or made known to the individual by us during
the course of the individual’s relationship with us be kept confidential and not disclosed to third parties. Our agreements
with employees and consultants also provide that inventions conceived by the individual in the course of rendering services to
us will be our exclusive property. Despite these efforts, we cannot provide any assurances that these agreements may not effectively
prevent disclosure of confidential information and may not provide an adequate remedy in the event of unauthorized disclosure
of confidential information. In addition, others may independently discover our trade secrets and proprietary information.

In
the event of unauthorized use or disclosure of trade secrets or proprietary information, these agreements, even if obtained